Technology
Health
Medical

electroCore

$7.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.57 (-6.95%) Today
-$0.57 (-6.95%) Today

Why Robinhood?

You can buy or sell electroCore and other stocks, options, ETFs, and crypto commission-free!

About

electroCore, Inc. Common Stock, also called electroCore, is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. Read More The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.

Employees
Headquarters
Basking Ridge, New Jersey
Founded
2005
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
High Today
$8.43
Low Today
$7.65
Open Price
$8.32
Volume
39.55K
52 Week High
52 Week Low

Collections

Technology
Health
Medical
Therapy
2018 IPO
US
North America

News

MarketBeatMar 11

Stock Price, News, & Analysis for Electrocore

electroCore, LLC, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields.

9

Earnings

-$0.53
-$0.50
-$0.48
-$0.45
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.53 per share
Actual
Available Mar 27, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.